treatment group to below 7%. Reaven said the initial average A1C of the whole group was about 9%.
During the intervention part of the study, the group getting usual care lowered their A1C to 8.4%. The intensive group had an average A1C of 6.9%. The intervention lasted nearly six years.
Approximately 10 years after the study began, the researchers found a 17% drop in the risk of heart disease and stroke.
“We wanted to learn if there was a continued benefit, a ‘legacy’ effect,” Reaven explained. And, at least in the short-term, it appeared there might be.
But the 15-year follow-up found no statistically significant difference in
